EC
| |
EcoR1 Capital, LLC13F | |
EcoR1 Capital, LLC | |
Last update 2025-04-18 | 59 Stocks (8 new) |
Value $2.65 Bil | Turnover 12 % |
EcoR1 Capital, LLC Top Holdings of 2024-12-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 11,890,843 | 379,436.8 | 0% | 14.350 | 0% | 9.560 | -41.70% | -45.19% | 2,198.2 | Biotechnology | |
ZYME | Zymeworks Inc | 15,028,079 | 220,011.1 | +11.84% | 8.320 | +0.88% | 21.820 | -13.85% | -14.14% | 874.6 | Biotechnology | |
CRNX | Crinetics Pharmaceuticals Inc | 4,288,120 | 219,251.6 | 0% | 8.290 | 0% | 4.620 | -16.50% | -36.65% | 3,032.6 | Biotechnology | |
JAZZ | Jazz Pharmaceuticals PLC | 1,706,469 | 210,151.7 | 0% | 7.950 | 0% | 2.820 | -9.21% | -10.03% | 6,729.2 | Biotechnology | |
PRTA | Prothena Corp PLC | 11,584,280 | 160,442.3 | 0% | 6.070 | 0% | 21.530 | -37.90% | -29.96% | 522.1 | Biotechnology | |
XNCR | Xencor Inc | 6,144,767 | 141,206.8 | +15.28% | 5.340 | +0.71% | 8.780 | -46.51% | -54.26% | 747.8 | Biotechnology | |
PFE
CALL
| Pfizer Inc | 5,000,000 | 132,650.0 | 0% | 5.010 | 0% | 0.090 | -12.15% | -12.18% | 129,989.7 | Drug Manufacturers | |
ARVN | Arvinas Inc | 6,726,491 | 128,946.8 | 0% | 4.870 | 0% | 9.780 | -50.11% | -52.79% | 622.4 | Biotechnology | |
ANAB | AnaptysBio Inc | 7,873,448 | 104,244.4 | +1.01% | 3.940 | +0.04% | 25.870 | +22.85% | +56.34% | 634.8 | Biotechnology | |
SRPT | Sarepta Therapeutics Inc | 770,000 | 93,624.3 | New Holding | 3.540 | +3.54% | 0.810 | -48.10% | -50.29% | 5,864.6 | Biotechnology |
EcoR1 Capital, LLC's Historical Top Holdings Breakdowns
EcoR1 Capital, LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2024-12-31 | New Buy | +3.54% | 104.54 ($122.56) 137.94 | $60.44 | -50.69% | New holding | 770,000 | 770,000 | |
QURE | uniQure NV | 2024-12-31 | New Buy | +2.27% | 4.54 ($8.7) 17.73 | $14.18 | 62.99% | New holding | 3,400,000 | 3,400,000 | |
SWTX | SpringWorks Therapeutics Inc | 2024-12-31 | New Buy | +2.13% | 28.61 ($34.98) 42.55 | $44.72 | 27.84% | New holding | 1,560,000 | 1,560,000 | |
CNTA | Centessa Pharmaceuticals PLC | 2024-12-31 | Sold Out | -1.76% | 15.04 ($16.56) 18.67 | $13.79 | -16.73% | Sold Out | 0 | -3,223,851 | |
VRDN | Viridian Therapeutics Inc | 2024-12-31 | Sold Out | -1.53% | 17.85 ($21.71) 25.71 | $13.50 | -37.82% | Sold Out | 0 | -1,958,847 | |
NUVB | Nuvation Bio Inc | 2024-12-31 | Sold Out | -1.51% | 2.01 ($2.58) 3.01 | $2.13 | -17.44% | Sold Out | 0 | -19,209,643 | |
KURA | Kura Oncology Inc | 2024-12-31 | Reduce | -1.50% | 8.51 ($14.31) 18.58 | $6.43 | -55.07% | Reduce -38.74% | 3,557,269 | -2,249,602 | |
PCVX | Vaxcyte Inc | 2024-12-31 | Sold Out | -1.38% | 80.97 ($99.04) 117.93 | $32.92 | -66.76% | Sold Out | 0 | -352,464 | |
EWTX | Edgewise Therapeutics Inc | 2024-12-31 | Sold Out | -1.14% | 26.63 ($31.91) 36.62 | $14.84 | -53.49% | Sold Out | 0 | -1,250,385 | |
ZYME | Zymeworks Inc | 2024-12-31 | Add | +0.88% | 12.19 ($14.01) 17.4 | $12.57 | -10.28% | Add 11.84% | 15,028,079 | 1,590,606 |
EcoR1 Capital, LLC Total Holding History ($B)
EcoR1 Capital, LLC's Asset Allocation
EcoR1 Capital, LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
EcoR1 Capital, LLC's Hypothetical Growth since 2024-12-31
EcoR1 Capital, LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
EcoR1 Capital, LLC's Holdings Heat Map
Size field:
EcoR1 Capital, LLC's Holdings Bubble Chart
EcoR1 Capital, LLC News
- 1